Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-102485
Filing Date
2025-08-05
Accepted
2025-08-05 09:39:57
Documents
1
Period of Report
2025-08-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 17961
  Complete submission text file 0000950170-25-102485.txt   19448
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41200 | Film No.: 251183241

Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Issuer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)